vimarsana.com

Olink Signature News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Olink Proteomics AB: Olink reports first quarter 2023 financial results

UPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) Olink Holding AB (publ) ("Olink") (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights

United statesUppsala lanOskar hjelmJan medinaAndrea pranderOlink holding ab nasdaqCorporate communicationsOlink holdingExplore kitJon heimerExplore kitsWall streetPrivate securities litigation reform actOlink signatureOlink flexOlink insight

Olink reports first quarter 2023 financial results

UPPSALA, Sweden, May 11, 2023 Olink Holding AB today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights First quarter 2023 revenue totaled. | May 11, 2023

Uppsala lanUnited statesOskar hjelmJan medinaAndrea pranderCorporate communicationsOlink holding ab nasdaqOlink holdingExplore kitJon heimerExplore kitsWall streetPrivate securities litigation reform actOlink signatureOlink flexOlink insight

Olink : Annual report and consolidated financial statements - Form 6-K

Annual report and consolidated financial statements for the financial year 1 January - 31 December 2022 Financial statements . | March 27, 2023

Uppsala lanUnited statesSouth koreaUnited kingdomNew yorkRobert schuerenRobert scheurenGustavo salemTina novaMary reumuthMary reumuth nicolas roelofsTinas novaKnilo investcoJohan lundFredrik norrmanSolange bullukian

Investegate |Olink Proteomics AB Announcements | Olink Proteomics AB: Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement

Investegate announcements from Olink Proteomics AB, Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement

Uppsala lanLeo joostenHead of researchDepartment of experimental medicineOlink holdingOlink exploreNext generation sequencingJon heimerOlink signatureExperimental medicineInflammatory diseaseInvestegate announcementsInvestegate company announcementsLink proteomics abLobenewswire and globenewswireதலை ஆஃப் ஆராய்ச்சி

vimarsana © 2020. All Rights Reserved.